These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22009459)

  • 21. Topical application of siRNA targeting cutaneous dendritic cells in allergic skin disease.
    Azuma M; Ritprajak P; Hashiguchi M
    Methods Mol Biol; 2010; 623():373-81. PubMed ID: 20217564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.
    Golzio M; Mazzolini L; Ledoux A; Paganin A; Izard M; Hellaudais L; Bieth A; Pillaire MJ; Cazaux C; Hoffmann JS; Couderc B; Teissié J
    Gene Ther; 2007 May; 14(9):752-9. PubMed ID: 17344906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An immobilized nanoparticle-based platform for efficient gene knockdown of targeted cells in the circulation.
    Huang Z; King MR
    Gene Ther; 2009 Oct; 16(10):1271-82. PubMed ID: 19554031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient delivery of siRNA using dendritic poly(L-lysine) for loss-of-function analysis.
    Inoue Y; Kurihara R; Tsuchida A; Hasegawa M; Nagashima T; Mori T; Niidome T; Katayama Y; Okitsu O
    J Control Release; 2008 Feb; 126(1):59-66. PubMed ID: 18055057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery.
    Shen Y; Wang B; Lu Y; Ouahab A; Li Q; Tu J
    Int J Pharm; 2011 Jul; 414(1-2):233-43. PubMed ID: 21545832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA interfering connective tissue growth factor prevents rat hepatic stellate cell activation and extracellular matrix production.
    Li G; Li D; Xie Q; Shi Y; Jiang S; Jin Y
    J Gene Med; 2008 Sep; 10(9):1039-47. PubMed ID: 18613219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting BCR-ABL fusion gene in Chronic Myeloid Leukemia cells.
    Arthanari Y; Pluen A; Rajendran R; Aojula H; Demonacos C
    J Control Release; 2010 Aug; 145(3):272-80. PubMed ID: 20403398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape.
    Bartz R; Fan H; Zhang J; Innocent N; Cherrin C; Beck SC; Pei Y; Momose A; Jadhav V; Tellers DM; Meng F; Crocker LS; Sepp-Lorenzino L; Barnett SF
    Biochem J; 2011 Apr; 435(2):475-87. PubMed ID: 21265735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer.
    Hsu T; Mitragotri S
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15816-21. PubMed ID: 21903933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RNAi mediated IL-6 in vitro knockdown in psoriasis skin model with topical siRNA delivery system based on liquid crystalline phase.
    Depieri LV; Borgheti-Cardoso LN; Campos PM; Otaguiri KK; Vicentini FT; Lopes LB; Fonseca MJ; Bentley MV
    Eur J Pharm Biopharm; 2016 Aug; 105():50-8. PubMed ID: 27224855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers.
    Ofek P; Fischer W; Calderón M; Haag R; Satchi-Fainaro R
    FASEB J; 2010 Sep; 24(9):3122-34. PubMed ID: 20385622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo cellular delivery of siRNA.
    Brink PR; Robinson RB; Rosen MR; Cohen IS
    IDrugs; 2010 Jun; 13(6):383-7. PubMed ID: 20506060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy.
    Mao CQ; Du JZ; Sun TM; Yao YD; Zhang PZ; Song EW; Wang J
    Biomaterials; 2011 Apr; 32(11):3124-33. PubMed ID: 21277018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic targeting in the silent era: advances in non-viral siRNA delivery.
    Guo J; Fisher KA; Darcy R; Cryan JF; O'Driscoll C
    Mol Biosyst; 2010 Jul; 6(7):1143-61. PubMed ID: 20431817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid delivery of small interfering RNA by biosurfactant MEL-A-containing liposomes.
    Inoh Y; Furuno T; Hirashima N; Kitamoto D; Nakanishi M
    Biochem Biophys Res Commun; 2011 Oct; 414(3):635-40. PubMed ID: 22001930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An intracellular delivery method for siRNA by an arginine-rich peptide.
    Wang YH; Hou YW; Lee HJ
    J Biochem Biophys Methods; 2007 Jun; 70(4):579-86. PubMed ID: 17320189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient and targeted delivery of siRNA in vivo.
    Shim MS; Kwon YJ
    FEBS J; 2010 Dec; 277(23):4814-27. PubMed ID: 21078116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. siRNA specific delivery system for targeting dendritic cells.
    Zheng X; Vladau C; Shunner A; Min WP
    Methods Mol Biol; 2010; 623():173-88. PubMed ID: 20217551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small interfering RNA (siRNA) delivery into monocyte-derived dendritic cells by electroporation.
    Prechtel AT; Turza NM; Theodoridis AA; Kummer M; Steinkasserer A
    J Immunol Methods; 2006 Apr; 311(1-2):139-52. PubMed ID: 16556448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrodynamic delivery protocols.
    Rychahou PG; Evers BM
    Methods Mol Biol; 2010; 623():189-95. PubMed ID: 20217552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.